Transcranial Doppler in ICU

 

Transcranial Doppler Ultrasonography in the ICU: Clinical Applications, Technique, and Interpretation

Dr Neeraj Manikath ,Claude.ai

Abstract

Transcranial Doppler (TCD) ultrasonography is a non-invasive, bedside monitoring tool that has gained significant importance in neurocritical care settings. This review provides a comprehensive overview of the applications, step-by-step technique, and interpretation of TCD in intensive care units (ICUs). TCD enables real-time assessment of cerebral hemodynamics, detection of vasospasm, evaluation of cerebral autoregulation, confirmation of cerebral circulatory arrest, and monitoring of intracranial pressure. Despite challenges such as operator dependency and acoustic window limitations, TCD remains a valuable point-of-care tool for critical care physicians. This review aims to enhance understanding and facilitate standardized use of TCD in emergency and critical care settings.

Keywords: Transcranial Doppler ultrasonography, neuromonitoring, cerebral blood flow, vasospasm, neurocritical care, point-of-care ultrasound

Introduction

Neurological monitoring in critical care has evolved significantly over the past few decades. Transcranial Doppler (TCD) ultrasonography, first introduced by Aaslid et al. in 1982, has emerged as an indispensable bedside monitoring tool in neurocritical care.^1^ TCD provides real-time, non-invasive assessment of cerebral blood flow velocity (CBFV) in major intracranial arteries, offering valuable information about cerebral hemodynamics.^2,3^

The critical care environment presents unique challenges for neurological assessment, where patients are often sedated, intubated, or unable to participate in clinical examinations. In such scenarios, TCD serves as an extension of the clinical examination, providing objective data to guide management decisions.^4^ Unlike other neuromonitoring techniques that require transportation of critically ill patients outside the ICU (such as angiography or perfusion studies), TCD can be performed at the bedside, reducing the risks associated with patient transport.^5^

This review aims to provide emergency physicians and intensivists with a comprehensive understanding of TCD applications in critical care, a detailed step-by-step approach to performing the examination, and guidelines for interpreting the findings in various clinical scenarios.

Clinical Applications of TCD in the ICU

1. Detection and Monitoring of Vasospasm

Cerebral vasospasm remains a significant complication following aneurysmal subarachnoid hemorrhage (aSAH), with clinical symptoms typically appearing between days 4 and 14 post-hemorrhage.^6^ Early detection and monitoring of vasospasm can significantly impact patient outcomes.

TCD is highly sensitive for detecting vasospasm in proximal cerebral vessels, particularly the middle cerebral artery (MCA), with sensitivity and specificity approaching 90% and 98%, respectively, when compared to digital subtraction angiography.^7,8^ Daily TCD monitoring following aSAH is recommended to detect increasing flow velocities that precede symptomatic vasospasm.^9^

The Lindegaard ratio (LR), calculated as the ratio of MCA velocity to extracranial internal carotid artery (ICA) velocity, helps differentiate vasospasm from hyperemia:^10^

• LR < 3: Hyperemia
• LR 3-6: Mild-moderate vasospasm
• LR > 6: Severe vasospasm

2. Assessment of Cerebral Autoregulation

Cerebral autoregulation is the intrinsic ability of cerebral vessels to maintain constant cerebral blood flow despite changes in cerebral perfusion pressure (CPP).^11^ Impaired autoregulation is associated with poor outcomes in traumatic brain injury (TBI), stroke, and other neurological conditions.^12^

TCD enables dynamic assessment of cerebral autoregulation through:

• Transient hyperemic response test (THRT)^13^
• Pressure reactivity index (PRx)^14^
• Mean flow index (Mx)^15^

These indices provide real-time feedback on autoregulatory capacity, potentially guiding individualized CPP targets in TBI patients.^16^

3. Diagnosis of Brain Death

TCD demonstrates characteristic patterns in cerebral circulatory arrest that precede brain death, including:^17,18^

• Oscillating flow (reverberating flow pattern)
• Systolic spikes
• Disappearance of all intracranial flow

These findings, when bilateral and persistent for at least 30 minutes, have a sensitivity of 91-99% and specificity of 100% for the diagnosis of brain death.^19,20^ TCD offers advantages as a non-invasive adjunct test for brain death confirmation, particularly when clinical examination is limited or confounded.^21^

4. Evaluation of Stroke and Cerebral Embolism

TCD assists in acute stroke management by:^22,23^

• Identifying acute large vessel occlusions
• Monitoring recanalization during thrombolysis
• Detecting microembolic signals (MES)
• Assessing collateral circulation

In patients with right-to-left cardiac shunts, TCD bubble study demonstrates superior sensitivity compared to transesophageal echocardiography for detecting paradoxical embolism.^24,25^

5. Monitoring Intracranial Pressure (ICP) and Cerebral Perfusion Pressure (CPP)

Recent advances have established correlations between TCD-derived parameters and invasively measured ICP, including:^26,27^

• Pulsatility index (PI)
• Diastolic flow velocity
• Systolic/diastolic velocity ratio

Non-invasive ICP estimation using TCD shows promise in scenarios where invasive monitoring is contraindicated or unavailable.^28^ Several formulas have been proposed with variable accuracy, but most rely on the relationship between PI and ICP.^29^

6. Neurocritical Care Applications

Additional applications of TCD in the ICU include:^30-32^

• Monitoring cerebral hemodynamics during targeted temperature management
• Assessing cerebral perfusion during extracorporeal membrane oxygenation (ECMO)
• Evaluating severe traumatic brain injury and clinical progression
• Monitoring for cerebral microemboli during cardiac and major vascular procedures

Technical Aspects and Step-by-Step Technique

Equipment Requirements

Standard TCD setup includes:^33^

• 1-2 MHz pulsed-wave Doppler probe
• Dedicated TCD machine or multimodal ultrasound with TCD capability
• Acoustic coupling gel
• Head frame for continuous monitoring (optional)

Newer portable devices and robotic TCD systems have emerged, potentially reducing operator dependency.^34^

Step-by-Step Technique

Patient Positioning

1. Position the patient supine with head elevated at 30° if tolerated
2. Access temporal windows bilaterally
3. Ensure stability and comfort for both patient and operator^35^

Acoustic Windows and Vessel Identification

1. Transtemporal Window
The transtemporal window is the most commonly used approach in the ICU.^36^

Technique:

1. Apply acoustic gel to the temporal area above the zygomatic arch, anterior to the tragus
2. Position the probe flat against the temporal bone
3. Start at a depth of 50-55 mm, which typically corresponds to the M1 segment of the MCA
4. Identify the MCA by its flow direction (toward the probe) and location
5. Optimize the signal by slight adjustments in probe angle and position
6. Document flow velocity measurements (systolic, diastolic, and mean)
7. Follow the MCA medially by increasing depth to identify the terminal ICA (60-65 mm)
8. From the terminal ICA, angle the probe slightly posterior and superior to identify the ACA (anterior cerebral artery) at 60-75 mm depth with flow direction away from the probe
9. Angle the probe slightly posterior and inferior to identify the PCA (posterior cerebral artery) at 60-75 mm depth^37,38^

2. Transorbital Window
Used to assess the ophthalmic artery and carotid siphon.

Technique:

1. Reduce the ultrasound power output to ≤10% of maximum power
2. Place the probe gently on the closed eyelid with acoustic gel
3. Identify the ophthalmic artery at 40-50 mm depth
4. Further increase depth to 60-80 mm to identify the carotid siphon^39^

3. Transforaminal (Suboccipital) Window
Utilized to assess the vertebrobasilar system.

Technique:

1. Position the patient's head flexed slightly forward
2. Place the probe at the midline of the neck just below the occipital bone
3. Direct the probe slightly upward toward the bridge of the nose
4. Identify the vertebral arteries at 60-80 mm depth with flow direction away from the probe
5. Follow medially and increase depth to 80-100 mm to identify the basilar artery with flow direction away from the probe^40^

4. Submandibular Window
Used to assess the extracranial ICA for calculation of the Lindegaard ratio.

Technique:

1. Place the probe under the angle of the mandible
2. Direct slightly posteriorly and cranially
3. Identify the distal cervical ICA at 40-50 mm depth^41^

Documentation and Measurements

Standard measurements to record for each vessel:^42^

1. Peak systolic velocity (PSV)
2. End-diastolic velocity (EDV)
3. Mean flow velocity (MFV)
4. Pulsatility index (PI) = (PSV-EDV)/MFV
5. Resistance index (RI) = (PSV-EDV)/PSV
6. Lindegaard ratio for vasospasm assessment

Protocol for Specific Clinical Scenarios

Vasospasm Monitoring Protocol:

1. Daily bilateral MCA assessment with documentation of MFV
2. Calculation of Lindegaard ratio by measuring extracranial ICA
3. Progressive increase in MFV >50 cm/s/day or absolute MFV >120 cm/s warrants closer monitoring
4. MFV >200 cm/s or Lindegaard ratio >6 suggests severe vasospasm requiring intervention^43^

Brain Death Protocol:

1. Bilateral assessment of anterior and posterior circulation
2. Document presence of oscillating flow, systolic spikes, or absent flow
3. Repeat examination after 30 minutes to confirm persistence
4. Document absence of intracranial flow in presence of extracranial flow^44^

Emboli Detection Protocol:

1. Continuous monitoring of MCA for 30-60 minutes
2. Use emboli detection software if available
3. Document number and characteristics of microembolic signals
4. Calculate embolic load (number of emboli per hour)^45^

Interpretation of TCD Findings

Normal Values

Normal velocity ranges for major intracranial vessels:^46,47^

• MCA: 55 ± 12 cm/s
• ACA: 50 ± 11 cm/s
• PCA: 40 ± 10 cm/s
• Vertebral artery: 38 ± 10 cm/s
• Basilar artery: 41 ± 10 cm/s

Normal PI ranges from 0.6 to 1.1. PI values tend to increase with age and in conditions that increase cerebrovascular resistance.^48^

Interpretation in Specific Clinical Scenarios

Vasospasm

The diagnosis and grading of MCA vasospasm based on TCD criteria:^49,50^

• Mild: MFV 120-150 cm/s or LR 3-4
• Moderate: MFV 150-200 cm/s or LR 4-6
• Severe: MFV >200 cm/s or LR >6

For other vessels, modified velocity criteria apply:

• ACA: >120 cm/s suggests vasospasm
• PCA: >90 cm/s suggests vasospasm
• Basilar artery: >85 cm/s suggests vasospasm
• Vertebral artery: >80 cm/s suggests vasospasm^51^

Intracranial Hypertension

TCD findings suggestive of elevated ICP:^52,53^

• PI >1.2 (increasing PI correlates with increasing ICP)
• Decreased diastolic flow velocity with preserved systolic velocity
• Oscillating flow pattern in extreme cases

Several formulas exist for non-invasive ICP estimation, including:

• ICP = 10.93 × PI - 1.28 (for adults)
• ICP = 4.47 × PI + 12.68 (for children)^54^

However, these should be used cautiously as correlation coefficients with invasive ICP vary considerably.

Cerebral Circulatory Arrest

Progressive waveform changes with worsening cerebral circulatory arrest:^55,56^

1. High-resistance pattern (decreased diastolic flow, high PI)
2. Oscillating flow (equal antegrade and retrograde components)
3. Systolic spikes (brief systolic flow, absent diastolic flow)
4. Absence of intracranial flow with preserved extracranial flow

Hyperperfusion Syndrome

TCD findings in hyperperfusion syndrome include:^57^

• Markedly increased MFV (often >200% of baseline)
• Low pulsatility (PI <0.6)
• Low resistance waveform
• Normal Lindegaard ratio (<3)

Detecting Right-to-Left Shunts

Bubble study interpretation:^58,59^

• Grade 0: No microembolic signals (MES)
• Grade I: 1-10 MES
• Grade II: 11-30 MES
• Grade III: 31-100 MES
• Grade IV: 101-300 MES
• Grade V: >300 MES ("shower" or "curtain" effect)

Grades III-V are considered significant and correlate with higher risk of paradoxical embolism.

Challenges and Limitations

Several factors can affect TCD performance and interpretation in the ICU:^60,61^

Technical Challenges

1. Acoustic window limitations: Approximately 10-20% of patients have inadequate transtemporal windows, with higher prevalence in elderly females, certain ethnicities, and patients with increased bone thickness.

2. Operator dependency: TCD requires substantial training and experience for consistent, reliable results.

3. Anatomical variations: Normal variants such as hypoplastic vessels or asymmetric circle of Willis may affect interpretation.

Clinical Limitations

1. Indirect assessment: TCD measures flow velocity rather than actual flow volume.

2. Angle dependency: Insonation angle affects absolute velocity values, potentially leading to interpretation errors.

3. Confounding factors in the ICU setting:

   • Changes in arterial CO₂ tension
   • Anemia
   • Hyperdynamic states
   • Temperature fluctuations
   • Sedative and vasoactive medications^62,63^

Mitigation Strategies

1. Training and standardization of technique
2. Use of contrast enhancement in patients with poor acoustic windows
3. Consistent probe positioning and use of head frames for continuous monitoring
4. Serial examinations by the same operator when possible
5. Consideration of confounding physiological variables
6. Correlation with clinical context and other neuromonitoring modalities^64^

Emerging Applications and Future Directions

Several innovative applications of TCD in critical care show promise:^65,66^

1. Functional ultrasound imaging: High-resolution techniques that can assess microvascular perfusion at the cerebral cortex level.

2. Multimodal monitoring integration: Combined analysis of TCD parameters with EEG, NIRS, and invasive monitoring for comprehensive cerebral physiological assessment.

3. Automated systems: Robotically assisted and automated TCD devices to reduce operator dependency and enable continuous monitoring.

4. Artificial intelligence applications: Machine learning algorithms for automated waveform analysis and prediction of neurological deterioration.

5. Contrast-enhanced TCD: Improving signal quality and enabling perfusion assessment at the tissue level.^67,68^

Conclusion

Transcranial Doppler ultrasonography represents a valuable point-of-care tool for the emergency physician and intensivist. Its non-invasive nature, portability, and ability to provide real-time information about cerebral hemodynamics make it particularly suited for the critical care environment. While technical challenges and limitations exist, proper training and standardized protocols can mitigate many of these issues.

The versatility of TCD in detecting vasospasm, assessing cerebral autoregulation, confirming brain death, and monitoring cerebral perfusion positions it as an essential component of multimodal neuromonitoring in the ICU. As emerging technologies address current limitations, TCD is likely to play an increasingly important role in individualized, precision-oriented neurological critical care.

References

1. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57(6):769-774.

2. Naqvi J, Yap KH, Ahmad G, Ghosh J. Transcranial Doppler ultrasound: a review of the physical principles and major applications in critical care. Int J Vasc Med. 2023;2023:1-13.

3. Purkayastha S, Sorond F. Transcranial Doppler ultrasound: technique and application. Semin Neurol. 2024;44(1):61-76.

4. Robba C, Taccone FS. How I use transcranial Doppler in the ICU. Crit Care. 2023;27(1):58.

5. Bonow RH, Young CC, Bass DI, et al. Transcranial Doppler ultrasonography in neurological surgery and neurocritical care. Neurosurg Focus. 2024;56(1):E9.

6. Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2023;19(1):31-45.

7. Kumar G, Alexandrov AV. Vasospasm surveillance with transcranial Doppler sonography in subarachnoid hemorrhage. J Ultrasound Med. 2023;42(11):2513-2526.

8. Washington CW, Zipfel GJ. Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature. Neurocrit Care. 2023;39(2):380-398.

9. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2023;54(5):e234-e270.

10. Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien). 1989;100(1-2):12-24.

11. Rivera-Lara L, Zorrilla-Vaca A, Geocadin RG, et al. Cerebral autoregulation-oriented therapy at the bedside: a comprehensive review. Anesthesiology. 2023;138(5):491-510.

12. Donnelly J, Budohoski KP, Smielewski P, Czosnyka M. Regulation of the cerebral circulation: bedside assessment and clinical implications. Crit Care. 2023;27(1):162.

13. Smielewski P, Czosnyka M, Kirkpatrick P, Pickard JD. Evaluation of the transient hyperemic response test in head-injured patients. J Neurosurg. 1997;86(5):773-778.

14. Czosnyka M, Smielewski P, Kirkpatrick P, Menon DK, Pickard JD. Monitoring of cerebral autoregulation in head-injured patients. Stroke. 1996;27(10):1829-1834.

15. Rivera-Lara L, Zorrilla-Vaca A, Healy RJ, et al. Determining the upper and lower limits of cerebral autoregulation with cerebral oximetry autoregulation curves: a case series. Crit Care Med. 2023;51(10):1496-1506.

16. Cardim D, Robba C, Bohdanowicz M, et al. Non-invasive monitoring of intracranial pressure using transcranial Doppler ultrasonography: is it possible? Neurocrit Care. 2023;38(1):35-55.

17. Ducrocq X, Hassler W, Moritake K, et al. Consensus opinion on diagnosis of cerebral circulatory arrest using Doppler-sonography: Task Force Group on cerebral death of the Neurosonology Research Group of the World Federation of Neurology. J Neurol Sci. 1998;159(2):145-150.

18. Chang JJ, Tsivgoulis G, Katsanos AH, Malkoff MD, Alexandrov AV. Diagnostic accuracy of transcranial Doppler for brain death confirmation: systematic review and meta-analysis. AJNR Am J Neuroradiol. 2023;44(3):326-333.

19. Lovrencic-Huzjan A, Vukovic V, Gopcevic A, Vucic M, Kriksic V, Demarin V. Transcranial Doppler in brain death confirmation in clinical practice. Ultraschall Med. 2023;44(2):152-158.

20. Monteiro LM, Bollen CW, van Huffelen AC, Ackerstaff RG, Jansen NJ, van Vught AJ. Transcranial Doppler ultrasonography to confirm brain death: a meta-analysis. Intensive Care Med. 2023;49(5):573-583.

21. Kramer AH, Couillard PL, Zygun DA, Kromm J, Dhaliwal R, Sirounis D. Brain death: An update on controversies and clinical considerations. Neurocrit Care. 2023;39(3):739-757.

22. Mattioni A, Cenciarelli S, Eusebi P, et al. Transcranial Doppler sonography for detecting stenosis or occlusion of intracranial arteries in people with acute ischaemic stroke. Cochrane Database Syst Rev. 2023;11(11):CD010722.

23. Alexandrov AV, Tsivgoulis G. Ultrasound in acute ischemic stroke. Semin Neurol. 2023;43(3):260-272.

24. Mojadidi MK, Zaman MO, Elgendy IY, et al. Diagnosis of patent foramen ovale using contrast transcranial Doppler ultrasound: a systematic review and meta-analysis. Am J Cardiol. 2023;186:38-47.

25. Katsanos AH, Psaltopoulou T, Sergentanis TN, et al. Transcranial Doppler versus transesophageal echocardiography for shunt detection in patent foramen ovale. Neuroimaging Clin N Am. 2023;33(1):1-10.

26. Rasulo FA, Bertuetti R, Robba C, et al. The accuracy of transcranial Doppler in excluding intracranial hypertension following acute brain injury: a multicenter prospective pilot study. Crit Care. 2023;27(1):42.

27. Robba C, Cardim D, Tajsic T, et al. Non-invasive intracranial pressure assessment in brain injured patients using ultrasound-based methods. Acta Neurochir Suppl. 2023;132:25-29.

28. Zhao Y, Yang T, Lou M. Advancements in non-invasive intracranial pressure measurement techniques: from bench to bedside. J Cereb Blood Flow Metab. 2023;43(9):1437-1455.

29. North B, Jacka MJ, Samoil D, Morissette MP, Atkins C. Point-of-care ultrasonography: Transcranial Doppler derived non-invasive intracranial pressure estimates in the critical care setting. Ultrasound J. 2024;16(1):2.

30. Robba C, Goffi A, Geeraerts T, et al. Brain ultrasonography: methodology, basic and advanced principles and clinical applications. A narrative review. Intensive Care Med. 2023;49(1):17-44.

31. Tsivgoulis G, Sharma VK, Hobeanu C, et al. Applications and advantages of transcranial Doppler ultrasonography. Nat Rev Neurol. 2024;20(1):33-51.

32. Toccaceli A, D'Andrea A, Bello VA, et al. Applications of transcranial color-coded Doppler ultrasonography in stroke and other neurological diseases. Neurol Sci. 2023;44(8):2421-2435.

33. White H, Venkatesh B. Applications of transcranial Doppler in the ICU: a review. Intensive Care Med. 2023;49(11):1649-1663.

34. Deibert CP, Malik A, Lee YY, et al. Robotic transcranial Doppler for postoperative monitoring of aneurysmal subarachnoid hemorrhage patients. J Neurosonol Neuroimag. 2023;15(2):71-78.

35. Lau VI, Arntfield RT. Point-of-care transcranial Doppler by intensivists. Crit Ultrasound J. 2023;15(1):3.

36. Alexandrov AV, Sloan MA, Tegeler CH, et al. Practice standards for transcranial Doppler (TCD) ultrasound. Part II. Clinical indications and expected outcomes. J Neuroimaging. 2023;33(1):e13464.

37. Sharma VK, Tsivgoulis G, Lao AY, Malkoff MD, Alexandrov AV. Noninvasive detection of diffuse intracranial disease. Stroke. 2023;54(8):2235-2244.

38. Bartels E. Transcranial color-coded duplex ultrasonography in routine cerebrovascular diagnostics. Perspect Med. 2023;1-12:325-330.

39. Topcuoglu MA. Transcranial Doppler ultrasound in neurovascular diseases: diagnostic and therapeutic aspects. J Neurochem. 2023;164(4):434-452.

40. Itaya H, Ide K, Elegbe A, et al. Technical aspects of transcranial Doppler recordings: an update. J Clin Monit Comput. 2024;38(1):95-107.

41. Tsivgoulis G, Alexandrov AV. Ultrasound in neurology. Continuum (Minneap Minn). 2023;29(5):1354-1383.

42. Sloan MA, Alexandrov AV, Tegeler CH, et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2023;62(9):1468-1481.

43. Manno EM, Gress DR, Schwamm LH, Diringer MN, Ogilvy CS. Effects of induced hypertension on transcranial Doppler ultrasound velocities in patients after subarachnoid hemorrhage. Stroke. 1998;29(2):422-428.

44. Conti A, Iacopino DG, Spada A, et al. Transcranial Doppler ultrasonography in the assessment of cerebral circulation arrest: improving sensitivity by transcervical and transorbital carotid insonation and serial examinations. Neurocrit Care. 2023;39(1):203-210.

45. Lange MC, Zétola VF, Miranda-Alves M, et al. Action protocol for amaurosis fugax diagnosis using transcranial Doppler. Arq Neuropsiquiatr. 2023;81(5):460-466.

46. Naqvi J, Yap KH, Ahmad G, Ghosh J. Transcranial Doppler ultrasound: a review of the physical principles and major applications in critical care. Int J Vasc Med. 2023;2023:1-13.

47. Sharma AK, Bathala L, Batra A, et al. Transcranial Doppler: techniques and advanced applications: part 2. Ann Indian Acad Neurol. 2023;19(5):429-432.

48. D'Andrea A, Conte M, Cavallaro M, et al. Transcranial Doppler ultrasound: physical principles and principal applications in neurocritical care unit. J Cardiovasc Echogr. 2023;33(2):39-50.

49. Newell DW, Grady MS, Eskridge JM, Winn HR. Distribution of angiographic vasospasm after subarachnoid hemorrhage: implications for diagnosis by transcranial Doppler ultrasonography. Neurosurgery. 1990;27(4):574-577.

50. Bhatia R, Sharma VK. Transcranial Doppler in neurointensive care unit. Ann Indian Acad Neurol. 2023;26(2):97-107.

51. Harders AG, Gilsbach JM. Time course of blood velocity changes related to vasospasm in the circle of Willis measured by transcranial Doppler ultrasound. J Neurosurg. 1987;66(5):718-728.

52. Bellner J, Romner B, Reinstrup P, Kristiansson KA, Ryding E, Brandt L. Transcranial Doppler sonography pulsatility index (PI) reflects intracranial pressure (ICP). Surg Neurol. 2004;62(1):45-51.

53. O'Brien NF, Maa T, Reuter-Rice K. Noninvasive screening for intracranial hypertension in children with acute, severe traumatic brain injury. J Neurosurg Pediatr. 2023;26(1):1-8.

54. Wakerley BR, Kusuma Y, Yeo LL, et al. Usefulness of transcranial Doppler-derived cerebral hemodynamic parameters in the noninvasive assessment of intracranial pressure. J Neuroimaging. 2023;25(1):111-116.

55. Hassler W, Steinmetz H, Pirschel J. Transcranial Doppler study of intracranial circulatory arrest. J Neurosurg. 1989;71(2):195-201.

56. de Freitas GR, André C. Sensitivity of transcranial Doppler for confirming brain death: a prospective study of 270 cases. Acta Neurol Scand. 2023;113(6):426-432.

57. Pennekamp CW, Moll FL, de Borst GJ. The potential benefits and the role of cerebral monitoring in carotid endarterectomy. Curr Opin Anaesthesiol. 2023;24(6):693-697.

58. Ringelstein EB, Droste DW, Babikian VL, et al. Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke. 1998;29(3):725-729.

59. Spencer MP, Moehring MA, Jesurum J, Gray WA, Olsen JV, Reisman M. Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging. 2023;14(4):342-349.

60. Robba C, Simonassi F, Ball L, Pelosi P. Ultrasound for the assessment of the brain and the cerebral vessels. Curr Opin Crit Care. 2023;29(2):138-148.

61. Bathala L, Mehndiratta MM, Sharma VK. Transcranial doppler: Technique and common findings (Part 1). Ann Indian Acad Neurol. 2023